Cargando…
Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
BACKGROUND: Mass drug administration (MDA) with ivermectin is the main strategy for onchocerciasis elimination. Ivermectin is generally safe, but is associated with serious adverse events in individuals with high Loa loa microfilarial densities (MFD). Therefore, ivermectin MDA is not recommended in...
Autores principales: | Blok, David J, Kamgno, Joseph, Pion, Sebastien D, Nana-Djeunga, Hugues C, Niamsi-Emalio, Yannick, Chesnais, Cedric B, Mackenzie, Charles D, Klion, Amy D, Fletcher, Daniel A, Nutman, Thomas B, de Vlas, Sake J, Boussinesq, Michel, Stolk, Wilma A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204788/ https://www.ncbi.nlm.nih.gov/pubmed/33289025 http://dx.doi.org/10.1093/cid/ciaa1829 |
Ejemplares similares
-
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study
por: Pion, Sébastien DS, et al.
Publicado: (2020) -
Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas
por: Niamsi-Emalio, Yannick, et al.
Publicado: (2021) -
“Test and not treat” for onchocerciasis control in a Loa
loa endemic area
por: Kamgno, Joseph, et al.
Publicado: (2017) -
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa–coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
por: Lenk, Edeltraud J, et al.
Publicado: (2020) -
Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia
por: Pion, Sébastien D., et al.
Publicado: (2016)